Juan María González Lahoz-rekin lankidetzan egindako argitalpenak (322)

2016

  1. Infection-related and -unrelated malignancies, HIV and the aging population

    HIV Medicine, Vol. 17, Núm. 8, pp. 590-600

2015

  1. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

    HIV Medicine, Vol. 16, Núm. 9, pp. 533-543

  2. Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study

    PLoS ONE, Vol. 10, Núm. 10

  3. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2014

  1. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

    Infection, Vol. 42, Núm. 4, pp. 757-762

  2. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study

    BMC Nephrology, Vol. 15, Núm. 1

  3. Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

    PLoS ONE, Vol. 8, Núm. 5

  2. Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study

    BMC Infectious Diseases, Vol. 13, Núm. 1

2012

  1. Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients

    AIDS, Vol. 26, Núm. 15, pp. 1917-1926

  2. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: The EuroSIDA study

    PLoS ONE, Vol. 7, Núm. 7

  3. Short communication: Does interleukin-28b single nucleotide polymorphisms influence the natural history of hepatitis b?

    AIDS Research and Human Retroviruses, Vol. 28, Núm. 10, pp. 1262-1264

2011

  1. A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy

    Journal of Infectious Diseases, Vol. 204, Núm. 5, pp. 741-752

  2. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

    AIDS, Vol. 25, Núm. 1, pp. 73-79

  3. HCV-specific T-Cell responses in HIV/Hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals

    Journal of Acquired Immune Deficiency Syndromes, Vol. 57, Núm. 1, pp. 1-8

  4. Manual del SIDA

    Permanyer

  5. Response to: Is the study power enough to say 'no difference'? by Geib et al

    Journal of Acquired Immune Deficiency Syndromes

  6. Risk factors for advanced liver fibrosis in HIV-infected individuals: Role of antiretroviral drugs and insulin resistance

    Journal of Viral Hepatitis, Vol. 18, Núm. 1, pp. 11-16

  7. Short communication: Severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regions

    AIDS Research and Human Retroviruses, Vol. 27, Núm. 9, pp. 965-967

  8. Short communication: Use of serum bilirubin levels as surrogate marker of early virological response to atazanavir-based antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 27, Núm. 10, pp. 1043-1045